Respiratory Motion, Inc. Raises $5.8M in First Closing of Series B Financing

WALTHAM, Mass., February 26, 2014Respiratory Motion, Inc. today announced that it has completed the first close of its Series B Preferred financing round. The Company has raised $5.8 million in the first closing and expects to raise up to an additional $3 million of capital, bringing the round to $8.8 million. 

The round is led by Easton Capital of New York, a leading life sciences-focused venture capital firm with strong participation from early investors. The funds raised will support sales and marketing of the Company’s innovative ExSpiron respiration monitoring system. 

See the full release here. 

Member Login
Welcome, (First Name)!

Forgot? Show
Log In
Enter Member Area
My Profile Not a member? Sign up. Log Out